Compare ANAB & CSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANAB | CSR |
|---|---|---|
| Founded | 2005 | 1970 |
| Country | United States | United States |
| Employees | N/A | 349 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2015 | N/A |
| Metric | ANAB | CSR |
|---|---|---|
| Price | $63.15 | $57.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 6 |
| Target Price | ★ $71.67 | $69.80 |
| AVG Volume (30 Days) | ★ 485.4K | 185.4K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 4.58% |
| EPS Growth | ★ 91.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $234,603,000.00 | N/A |
| Revenue This Year | N/A | $1.24 |
| Revenue Next Year | $52.14 | $2.72 |
| P/E Ratio | ★ N/A | $62.27 |
| Revenue Growth | ★ 157.01 | N/A |
| 52 Week Low | $17.11 | $52.76 |
| 52 Week High | $73.30 | $69.61 |
| Indicator | ANAB | CSR |
|---|---|---|
| Relative Strength Index (RSI) | 59.71 | 38.79 |
| Support Level | $52.32 | $57.05 |
| Resistance Level | $67.69 | $60.30 |
| Average True Range (ATR) | 3.05 | 1.79 |
| MACD | 0.99 | 0.14 |
| Stochastic Oscillator | 93.72 | 53.58 |
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.